Save Your Liver foundation, SYLiF, an affiliate of the World Hepatitis Alliance (WHA) under the World Health Organization, is a Liver-Health centered Non-Governmental Organization committed to liver health policy advocacy and awareness creation on liver health.
The organization’s mission is to ensure the institutionalization of liver health policies in Africa as part of a global network to create liver awareness through Research, policy advocacy, education and programme interventions in partnership with government, academia, donor agencies and health related corporate industry players.
The organization was established in January 2007 but formally registered and inaugurated in January 2009 with the support of the Ministry of Health. The Foundation is the first of its kind in Ghana and sub-Saharan Africa devoted to the crusade against liver diseases and to ensure optimum Liver health consciousness as part of global effort towards ensuring Progressive Liver health attitudes among people.
The formation of Save Your Liver Foundation was inspired by Nyaaba-Aweeba Azongo, the President of the Foundation, a development consultant and researcher in Ghana with Health planning background, and Mr. Christian Addai, the Executive Director of the Foundation , a leading health practitioner with health planning background and extensive experience in Health care in Ghana. The foundation has a staff strength of 21 and about 3000 volunteers throughout the Country and is currently planning to extend its activities to Nigeria and other francophone countries in the West African Sub-Region.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close